This Week in Devices [ Thanksgiving Edition ]: Misfit Wearables Shines; Device Tax Leads to Layoffs at Strkyer; An Innovation for Glaucoma Patients

This Week in Devices [ 11/21/12]:

Misfit Wearables seeks crowdfunding for its new product. FDA doesn't like St. Jude's pacemaker leads. Getting laid off at Strkyer? Blame the device tax. A device that may replace eyedrops for glaucoma patients. Sea creatures inspire a new device for the fight against cancer.
Misfit Wearables Unveils the Shine
Misfit Wearables, a company dedicated to creating the next wave of wearable technology, has announced a crowdfunding campaign for its first product, the Misfit Shine. The tiny, stylish activity monitor can be synced to a smartphone to monitor a variety of user activities. [IndieGogo]
FDA tisk-tisks St. Jude Pacemaker Leads
A recent report by the United States Food and Drug Administration showed a significant number of problems with St. Jude Medical’s Datura pacemaker leads. The report spooked investors and led to an 11 percent decrease in stock prices for the company. [Qmed]

Stryker Blames Medical Device Tax for Layoffs
Amidst an announcement that it will be laying off 1000-1200 employees, Stryker has claimed that the staff reduction is necessary in order to keep up with costs associated with the medical device tax. [Qmed]

Ultra-Small Device Promises New Relief for Glaucoma Patients
At the 116th Annual Meeting of the American Academy of Ophthalmology researchers announced the results of clinical trials of the Hydrus Microstent. The device, which is no larger than an eyelash, is used to relieve pressure in glaucoma patients – protecting them from vision loss or blindness. [Ivantis Inc]
A Cancer-Fighting Device, Inspired by Marine Life
A new microchip device, inspired by the appendages of the jellyfish and other sea creatures, may have therapeutic use in fighting cancer. The device could potentially be used to detect, bind, and capture cancer cells in a patient. [Medical News Today]